Imaging multidrug resistance with 4-[18F]fluoropaclitaxel
- 31 October 2007
- journal article
- review article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 34 (7) , 823-831
- https://doi.org/10.1016/j.nucmedbio.2007.04.011
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Multidrug Transporters as Drug TargetsCurrent Drug Targets, 2006
- Multidrug resistance transporters and modulationCurrent Opinion in Oncology, 2000
- Visualization of multidrug resistance in vivoEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*Clinical Pharmacology & Therapeutics, 1997
- The barrier function of CYP3A4 and P-glycoprotein in the small bowelAdvanced Drug Delivery Reviews, 1997
- Modulation and prevention of multidrug resistance by inhibitors of P-glycoproteinCancer Chemotherapy and Pharmacology, 1997
- Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killingCancer Chemotherapy and Pharmacology, 1996
- MDR Expression in Normal Tissues: Pharmocologic Implication for the Clinical Use of P-Glycoprotein InhibitorsHematology/Oncology Clinics of North America, 1995
- Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograftBiochemical Pharmacology, 1994
- Detection of P-Glycoprotein With Four Monoclonal Antibodies in Normal and Tumor TissuesJAMA Otolaryngology–Head & Neck Surgery, 1993